Stonepine Capital Management, LLC: 13F holdings
CIK 14407712026Q2
| Positions | 83 |
|---|---|
| Reported value | $390.3m |
| Filed | 2026-08-17 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| RADIOPHARM THERANOSTICS LTD | 51,000,000 | $213.7m | 54.8% |
| VERASTEM INC | 3,349,627 | $12.8m | 3.3% |
| EVOLUS INC | 1,590,162 | $11.0m | 2.8% |
| TENAX THERAPEUTICS INC | 660,000 | $9.6m | 2.5% |
| NEKTAR THERAPEUTICS | 120,654 | $8.4m | 2.2% |
| ADMA ADMA BIOLOGICS INC | 740,000 | $6.2m | 1.6% |
| CAMP4 THERAPEUTICS CORP | 1,389,622 | $6.1m | 1.6% |
| ELOXX PHARMACEUTICALS INC | 397,160 | $5.5m | 1.4% |
| KAZIA THERAPEUTICS LTD | 345,179 | $4.9m | 1.2% |
| INDIVIOR PHARMACEUTICALS INC | 100,000 | $4.1m | 1.1% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1440771")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.